Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1056 of 1,261
  1. US 7396848

    Neurotrophin production/secretion promoting agent

    Takeda Pharmaceutical Company Limited · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  2. US 7396682

    Method for cell adhesion and wound healing

    REGENBiotech, Inc. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  3. US 7396542

    Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted
  4. EP 1938801

    Nanoemulsion

    BIOFRONTERA BIOSCIENCE GMBH [DE] · Granted Jul 2, 2008 · Expires Jun 27, 2028

    granted
  5. US 7393833

    Chimeric proteins with phosphatidylserine binding domains

    The Board of Regents of the University of Oklahoma · Granted Jul 1, 2008 · Expires Jun 26, 2028

    granted
  6. US 7393994

    Transgenic mouse model for neurodegenerative diseases

    The Regents of the University of California · Granted Jul 1, 2008 · Expires Jun 26, 2028

    granted
  7. US 7393842

    Pyrazole analogs acting on cannabinoid receptors

    UNIVERSITY OF CONNECTICUT · Granted Jul 1, 2008 · Expires Jun 26, 2028

    granted
  8. US 7393544

    Dispersion for pulmonary delivery of a bioactive agent

    Nektar Therapeutics · Granted Jul 1, 2008 · Expires Jun 26, 2028

    granted
  9. US 7393855

    2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and pyrimidines as antiviral agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 1, 2008 · Expires Jun 26, 2028

    granted
  10. CA 2670932

    DETECTION DU DETACHEMENT D'UN AGENT DE CONTRASTE IMMOBILISE DANS DES APPLICATIONS D'IMAGERIE MEDICALE

    BRACCO INT BV [NL] · Granted Jun 26, 2008 · Expires Jun 21, 2028

    granted
  11. CA 2673419

    COMPOSITION PHARMACEUTIQUE

    GENERICS UK LTD [GB] · Granted Jun 26, 2008 · Expires Jun 21, 2028

    granted
  12. CA 2673418

    COMPOSE ET COMPOSITION PHARMACEUTIQUES

    ALPHAPHARM PTY LTD [AU] · Granted Jun 26, 2008 · Expires Jun 21, 2028

    granted
  13. US 7390625

    Apoptosis-associated protein and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  14. US 7390813

    Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  15. US 7390815

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  16. US 7390510

    Preparation of hypericin bonded with poly-N-vinylamides

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  17. US 7390646

    Bacterial vectors and methods of use thereof

    The Regents of the University of California · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  18. US 7390668

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  19. US 7390807

    Crystal forms of lamotrigine and processes for their preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  20. US 7390808

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted
  21. AU 2007332640

    Powder formulation for valganciclovir

    HOFFMANN LA ROCHE [DE] · Granted Jun 19, 2008 · Expires Jun 14, 2028

    granted
  22. US 7387881

    Detection and treatment of cancers of the liver

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  23. US 7387792

    Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration

    Collegium Pharmaceutical, Inc. · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted
  24. US 7388002

    Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases

    BioCryst Pharmaceuticals, Inc. · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.